Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0))

Craig Reynolds; Alexander I. Spira; Larry Gluck; Suzanne J. Bradie-Muller; Feng Zhan; Kristi A. Boehm; Lina Asmar

doi:10.1007/s10637-013-9996-x

Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0))

Craig Reynolds, Alexander I. Spira, Larry Gluck, Suzanne J. Bradie-Muller, Feng Zhan, Kristi A. Boehm, Lina Asmar

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1628
Number of pages	1
Journal	Investigational New Drugs
Volume	31
Issue number	6
DOIs	https://doi.org/10.1007/s10637-013-9996-x
State	Published - Dec 2013
Externally published	Yes

ASJC Scopus subject areas

Oncology
Pharmacology
Pharmacology (medical)

Access to Document

10.1007/s10637-013-9996-x

Cite this

Reynolds, C., Spira, A. I., Gluck, L., Bradie-Muller, S. J., Zhan, F., Boehm, K. A., & Asmar, L. (2013). Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0)). Investigational New Drugs, 31(6), 1628. https://doi.org/10.1007/s10637-013-9996-x

Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0)). / Reynolds, Craig; Spira, Alexander I.; Gluck, Larry et al.
In: Investigational New Drugs, Vol. 31, No. 6, 12.2013, p. 1628.

Research output: Contribution to journal › Comment/debate › peer-review

Reynolds, C, Spira, AI, Gluck, L, Bradie-Muller, SJ, Zhan, F, Boehm, KA & Asmar, L 2013, 'Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0))', Investigational New Drugs, vol. 31, no. 6, pp. 1628. https://doi.org/10.1007/s10637-013-9996-x

@article{56367a39f48f4370b6b9dc12a2f0cbea,

title = "Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0))",

author = "Craig Reynolds and Spira, {Alexander I.} and Larry Gluck and Bradie-Muller, {Suzanne J.} and Feng Zhan and Boehm, {Kristi A.} and Lina Asmar",

year = "2013",

month = dec,

doi = "10.1007/s10637-013-9996-x",

language = "English (US)",

volume = "31",

pages = "1628",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

number = "6",

}

TY - JOUR

T1 - Erratum

T2 - Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0))

AU - Reynolds, Craig

AU - Spira, Alexander I.

AU - Gluck, Larry

AU - Bradie-Muller, Suzanne J.

AU - Zhan, Feng

AU - Boehm, Kristi A.

AU - Asmar, Lina

PY - 2013/12

Y1 - 2013/12

UR - http://www.scopus.com/inward/record.url?scp=84888643376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888643376&partnerID=8YFLogxK

U2 - 10.1007/s10637-013-9996-x

DO - 10.1007/s10637-013-9996-x

M3 - Comment/debate

AN - SCOPUS:84888643376

SN - 0167-6997

VL - 31

SP - 1628

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 6

ER -

Erratum: Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (Investigational New Drugs DOI:10.1007/s10637-013-9985-0))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this